CF
SBBP

Centaurus Financial’s Strongbridge Biopharma plc. SBBP Stock Holding History

Centaurus Financial’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36,500
Closed -$101K – 943
2021
Q1 		$101K Hold
36,500
– – 0.01% 789
2020
Q4 		$89K Buy
36,500
+10,000
+38% +$24.1K 0.01% 759
2020
Q3 		$56K Buy
26,500
+16,500
+165% +$55.6K 0.01% 633
2020
Q2 		$38K Hold
10,000
– – 0.01% 613
2020
Q1 		$19K Hold
10,000
– – ﹤0.01% 519
2019
Q4 		$21K Buy
+10,000
New +$19.2K ﹤0.01% 627

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Centaurus Financial's SBBP Position: Q2 2021 in Review

Centaurus Financial sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 36,500 shares — an estimated $101K sold.

Centaurus Financial first reported a position in SBBP in Q4 2019 and held it in 6 quarters. The position peaked at $101K in Q1 2021. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Centaurus Financial reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Centaurus Financial sold 36,500 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $101K.
  • Centaurus Financial first reported a position in Strongbridge Biopharma plc. in Q4 2019 and held it in 6 quarters.
  • Centaurus Financial's Strongbridge Biopharma plc. position peaked at $101K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Centaurus Financial's 13F filing for Q2 2021, filed 10 Aug 2021.